Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep845 | Late Breaking | ECE2021

Importance of proper diagnosis and treatment challenges in a 16-year-old patient with ectopic posterior pituitary and panhypopituitarism - a rare case report

Stanciu Mihaela , Paula Ristea Ruxandra

BackgroundPosterior pituitary ectopia is a rare congenital condition that consists of the abnormal position of the distinctly hyperintense signal suggestive of the posterior pituitary gland on magnetic resonance imaging. The classical features include the ectopic location of the posterior pituitary gland, pituitary stalk abnormalities and associated clinical manifestations related to isolated growth hormone deficiency. In rare cases, some patients suffer...

ea0099ep720 | Adrenal and Cardiovascular Endocrinology | ECE2024

Emerging endocrine complications in cancer immunotherapy

Paula Ristea Ruxandra , Puscas Teodora , Zaharia Claudiu , Tutovan Serghei , Stanciu Mihaela

Introduction: Immune-checkpoint inhibitors (ICIs) have revolutionised cancer treatment, offering superior efficacy compared to traditional chemotherapy. The use of immune checkpoint inhibitors has been associated with the occurrence of multiple endocrine immune-related adverse events (irAEs), such as primary hypothyroidism, thyroiditis, primary adrenal insufficiency, type 1 diabetes mellitus, and hypophysitis. In certain instances, these irAEs may necessitate the discontinuati...

ea0099ep718 | Pituitary and Neuroendocrinology | ECE2024

Acromegaly and multiple myeloma: a case report

Paula Ristea Ruxandra , Puşcaş Teodora , Zaharia Claudiu , Tutovan Serghei , Stanciu Mihaela

Introduction: Acromegaly is a progressive disorder caused by excess growth hormone (GH), usually due to a GH-secreting pituitary adenoma, associated with an increased risk of cancer-related mortality. Insulin-like growth factor 1 (IGF-1) has been involved in tumor development by promoting cell proliferation and inhibiting apoptosis. Multiple myeloma (MM), a plasma cell neoplasm, has been suggested to have a potential link to IGF-1 in its pathogenesis.Cas...

ea0099ep531 | Thyroid | ECE2024

Differentiated thyroid carcinoma in graves disease

Paula Ristea Ruxandra , Puşcaş Teodora , Zaharia Claudiu , Tutovan Serghei , Stanciu Mihaela

Introduction: Recent studies have revealed that thyroid autoimmunity and thyroid cancer may coexist, although a pathogenic relationship has not been clearly established. GravesÂ’ disease (GD) is an autoimmune thyroid disease and is considered the most common cause of hyperthyroidism. Thyroid cancer is the most common malignancy of the endocrine system and represents the eighth most diagnosed cancer worldwide. Although in patients with GD, the presence of thyroid nodules is...